No Prescription |
 |
 | ||
|
RANITIDINE Generic Zantac |
|
| ||
No Prescription » Prescription Drugs 14 » RANITIDINE Generic Zantac Ranitidine is used to treat ulcers; gastroesophageal reflux disease (GERD) a condition in which backward flow of acid from the stomach causes heartburn and injury of the food pipe (esophagus); and conditions where the stomach produces too much acid such as Zollinger-Ellison syndrome. Over-the-counter ranitidine is used to prevent and treat symptoms of heartburn associated with acid indigestion and sour stomach. Ranitidine is in a class of medications called H2 blockers. It decreases the amount of acid made in the stomach.How should this medicine be used? Ranitidine comes as a tablet an effervescent tablet effervescent granules and a syrup to take by mouth. It is usually taken once a day at bedtime or two to four times a day. Over-the-counter ranitidine comes as a tablet to take by mouth. It is usually taken once or twice a day. To prevent symptoms it is taken 30-60 minutes before eating or drinking foods that cause heartburn. Follow the directions on your prescription or the package label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take ranitidine exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.Dissolve ranitidine effervescent tablets and granules in a full glass (6-8 ounces) of water before drinking.Do not take over-the-counter ranitidine for longer than 2 weeks unless your doctor tells you to. If symptoms of heartburn acid indigestion or sour stomach last longer than 2 weeks stop taking ranitidine and call your doctor. Buy RANITIDINE Generic Zantac and other Prescription Drugs 14 products online at Medstore. Buy Online at Medstore - Click Here!
About RANITIDINE Generic Zantac: Product Type: Prescription Drugs 14 RANITIDINE ( Generic Zantac) RANITIDINE (Generic Zantac) Generic Zantac 150mg Tabs Generic Zantac RANITIDINE
View more Prescription Drugs 14 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
